Clinical Nurse Specialist, Gerontology · Peoria, IL
NPI
1073917258
Since 2014
Specialty
Clinical Nurse Specialist, Gerontology
Code 364SG0600X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
3308 W Chartwell Rd
Peoria, IL, 61614
Phone (309) 691-7640
Groups this clinician bills Medicare through
Medicare paid, 2024
$39K
1,131 services
Medicare patients, 2024
245
Average age 71
Drug cost, 2024
$3.9M
6,682 prescriptions
Company payments, 2025
$155
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marissa C Myres was code 99213 (office e&m - established), 583 times for 237 patients. In total Marissa C Myres billed 1,131 services in 7 codes, and Medicare paid $39K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-12-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 583 | 237 | $51.87 | $30K |
| 83036 Blood Count | Office | 481 | 213 | $9.50 | $4,571 |
| G0008 Administration of influenza virus vaccine | Office | 20 | 20 | $31.15 | $623 |
| 90653 Vaccine Product | Office | 17 | 17 | $73.50 | $1,250 |
| 99215 Office E&M - Established | Office | 15 | 15 | $102.07 | $1,531 |
By year: 2022 $25K for 498 services; 2023 $32K for 836 services; 2024 $39K for 1,131 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 481 | 213 | $9.50 | $4,571 |
Medicare prescription drug claims, 2024
In 2024, the drug Marissa C Myres prescribed most often to Medicare patients was Metformin Hcl, with 449 prescriptions and refills. In total Marissa C Myres wrote 6,682 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metformin Hcl Generic | 449 | 1,245 | 145 | $3,385 |
| Jardiance Empagliflozin | 431 | 975 | 126 | $556K |
| Ozempic Semaglutide | 418 | 563 | 98 | $521K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 399 | 905 | 147 | $62K |
| Metformin Hcl Er Metformin Hcl | 343 | 882 | 120 | $3,124 |
| Mounjaro Tirzepatide | 277 | 349 | 78 | $367K |
| Trulicity Dulaglutide | 237 | 345 | 69 | $329K |
| Glimepiride Generic | 235 | 639 | 84 | $2,023 |
| Novolog Flexpen Insulin Aspart | 216 | 446 | 99 | $80K |
| Tresiba Flextouch U-200 Insulin Degludec | 204 | 421 | 68 | $405K |
| Glipizide Er Glipizide | 192 | 540 | 62 | $2,911 |
| Glipizide Generic | 177 | 509 | 61 | $1,471 |
| Humalog Kwikpen U-100 Insulin Lispro | 171 | 370 | 70 | $77K |
| Tresiba Flextouch U-100 Insulin Degludec | 145 | 348 | 57 | $111K |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 143 | 375 | 56 | $18K |
Brand drugs: 3,882 claims; generic drugs: 2,023 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marissa C Myres $155 ($155 in general payments such as food, travel and fees) from 4 companies. The largest payer was Tandem Diabetes Care, Inc. with $73.67.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.